Helsinn Group Competitors and Similar CompaniesClear all
Helsinn Group's competitors and similar companies include TriSalus Life Sciences, Navigen, NATCO Pharma and Kinnate Biopharma.
 Helsinn Group Helsinn Group is a pharmaceutical company that focuses on therapeutic and supportive care products for cancer. |  TriSalus Life Sciences TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors. |  NATCO Pharma NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). |  Kinnate Biopharma Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. | ||
Founding Date | Founding Date 1976 | Founding Date 2009 | Founding Date 2006 | Founding Date 1981 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Pazzallo, CH HQ Shanghai, CN Monaco, MC Biasca, CH Woodbridge Township, US | Locations Westminster, US HQ Bannockburn, US Cranston, US | Locations Salt Lake City, US HQ | Locations Hyderabad, IN HQ Central Hope Town, IN Chennai, IN Hyderabad, IN Santola, IN Vijayapuri North, IN | Locations San Diego, US HQ |
Employees | Employees 3731% decrease | Employees 106 | Employees 13 | Employees 4,016 | Employees 2757% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 117.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 125 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $45.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹44.1b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $7m (FY, 2025) | Cost of goods N/A | Cost of goods ₹7.5b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $38.2m (FY, 2025) | Gross profit N/A | Gross profit ₹37b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($39.2m) (FY, 2025) | Net income N/A | Net income ₹18.8b (FY, 2025) | Net income ($112.6m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 52.2m | Total funding raised $ 1.7m | Total funding raised N/A | Total funding raised $ 172.5m |
For sources of this data, please see the company profile
View Company Profiles
TriSalus Life Sciences
HQ
Westminster, US
Employees
106
TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.
View company
Navigen
HQ
Salt Lake City, US
Employees
13
Navigen is a pharmaceutical discovery and development company.
View companyNATCO Pharma
HQ
Hyderabad, IN
Employees
4,016
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
View companyKinnate Biopharma
HQ
San Diego, US
Employees
27
Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.
View company